IOSP
Innospec Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $43.7M | first quarter ended March 31, 2026 | — |
|
|
|||
| Net cash non-GAAP | $289.1M | first quarter ended March 31, 2026 | — |
| Share repurchases | $6.2M | first quarter | — |
| Adjusted non-GAAP EPS non-GAAP | $5.27 | Full Year | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IOSP
this stock
Innospec Inc.
|
$2.10B | +11.7% | -3.7% | 18.7 | 2.0% |
|
LIN
Linde PLC
|
$240.89B | +21.0% | +3.0% | 34.5 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$125.91B | +7.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.40B | +4.9% | +26.4% | 32.5 | 3.2% |
|
ECL
Ecolab Inc.
|
$77.60B | +3.2% | +2.2% | 37.3 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IOSP | +5.9% | +2.1% | +4.7% | +5.0% | +11.7% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | +6.0% | +2.0% | -4.3% | +4.5% | +1.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.